Status:
COMPLETED
Autohypnosis and Cancerology
Lead Sponsor:
Groupe Hospitalier Mutualiste de Grenoble
Collaborating Sponsors:
TIMC-IMAG
AG2R La Mondiale
Conditions:
Colorectal Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Therapeutical hypnosis is proven to be an effective medical support to chemotherapy: it was shown that it can reduce the pain, anxiety, fatigue felt by the patient. Yet, hypnosis requires the presenc...
Eligibility Criteria
Inclusion
- Age superior or equal to 18 years old
- Colorectal or breast cancer history, treated by surgery and that should undergo an adjuvant chemotherapy
- In the case of breast cancer, adjuvant chemotherapy must involve anthracyclines
- ECOG performance score \< 3
- Patient must be affiliated or beneficiary of social security or any similar regime
Exclusion
- Patients already included in another interventional clinical research protocol
- Patients unable to proceed to hypnosis treatment due to their speech limitations (poor comprehension and expression of french, deafness, mental illness)
- Patients protected by French law from clinical inclusion ( pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation...)
Key Trial Info
Start Date :
May 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03429296
Start Date
May 23 2018
End Date
July 1 2022
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe hospitalier Mutualiste de Grenoble
Grenoble, France, 38028